奥地利关于高伤性心肌病的诊断和管理的共识声明
Nicolas Verheyen1, Johannes Auer2,3, Nikolaos Bonaros4
1Division of Cardiology, Department of Internal Medicine, Medical University of Graz, Auenbruggerplatz 15, 8036, Graz, Austria. nicolas.verheyen@medunigraz.at.
Wiener klinische Wochenschrift
|October 1, 2024
概括
缺血性心肌病 (HCM) 是一种遗传性心脏病,在奥地利影响了数千人. 早期诊断和新的治疗方法,如心脏肌化素抑制剂,改善了患者的护理和结果.
科学领域:
- 心脏病学 心脏病学
- 遗传学 是一个遗传学.
- 内部医学 内部医学
背景情况:
- 增高性心肌病变 (HCM) 是最常见的遗传性心脏病.
- 它的特征是无法解释的左心室缩.
- HCM显著影响生活质量,并带有突然心脏死亡的风险.
研究的目的:
- 提供奥地利关于HCM的共识声明.
- 为奥地利医疗保健环境总结国际指导方针建议.
- 在可访问的算法中呈现诊断和管理策略.
主要方法:
- 对奥地利的国际流行病学数据的审查.
- 综合当前关于HCM的国际指导方针.
- 开发基于共识的建议和算法.
主要成果:
- 据估计,奥地利有20,000至40,000人受到影响.
- 由于各种表现,诊断可能具有挑战性.
- 新的治疗选择,包括心脏肌 ATPase 抑制剂,是可用的.
结论:
- 及早和准确的诊断,包括基因检测,至关重要.
- 综合性患者和家庭咨询是必不可少的.
- 更新的管理策略,包括新疗法,对于改善HCM的结果至关重要.
相关概念视频
Cardiomyopathy III: Hypertrophic Cardiomyopathy
1
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
1
Cardiomyopathy V: Interprofessional Care
2
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
2
Cardiomyopathy II: Dilated Cardiomyopathy
1
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
1
Rheumatic Heart Disease III: Medical Management
3
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
3
Myocarditis III: Medical Management
2
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
2
Cardiomyopathy IV: Restrictive Cardiomyopathy
2
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
2


